129 related articles for article (PubMed ID: 33896970)
1. Is serum complement C1q related to major depressive disorder?
Yang J; Li R; Shi Y; Jiang S; Liu J
Indian J Psychiatry; 2020; 62(6):659-663. PubMed ID: 33896970
[TBL] [Abstract][Full Text] [Related]
2. Increased serum levels of complement C1q in major depressive disorder.
Yao Q; Li Y
J Psychosom Res; 2020 Jun; 133():110105. PubMed ID: 32272297
[TBL] [Abstract][Full Text] [Related]
3. The differences in serum C1q levels between first-episode patients with bipolar disorder and major depressive disorder.
Chen Q; Sun T; Li D; Zhao Z; Li Y
J Psychosom Res; 2022 Nov; 162():111042. PubMed ID: 36156342
[TBL] [Abstract][Full Text] [Related]
4. Plasma complement C3 and C3a are increased in major depressive disorder independent of childhood trauma.
Luo X; Fang Z; Lin L; Xu H; Huang Q; Zhang H
BMC Psychiatry; 2022 Nov; 22(1):741. PubMed ID: 36447174
[TBL] [Abstract][Full Text] [Related]
5. Multiple Complement Pathway-related Proteins Might Regulate Immunopathogenesis of Major Depressive Disorder.
Reddy PV; Talukdar PM; Subbanna M; Bhargav PH; Arasappa R; Venkatasubramanian G; Muralidharan K; Debnath M
Clin Psychopharmacol Neurosci; 2023 May; 21(2):313-319. PubMed ID: 37119224
[TBL] [Abstract][Full Text] [Related]
6. Study of decreased serum levels of C1q/TNF-related protein 4 (CTRP4) in major depressive disorder.
Chen Q; Sun T; He Q; Yu J; Zhang X; Han L; Ren Y
J Psychiatr Res; 2024 Apr; 172():274-280. PubMed ID: 38417323
[TBL] [Abstract][Full Text] [Related]
7. Plasma complement component 4 increases in patients with major depressive disorder.
Wei J; Liu Y; Zhao L; Yang X; Ni P; Wang Y; Li T; Ma X
Neuropsychiatr Dis Treat; 2018; 14():37-41. PubMed ID: 29302190
[TBL] [Abstract][Full Text] [Related]
8. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls.
Kurita H; Maeshima H; Kida S; Matsuzaka H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
J Affect Disord; 2013 Apr; 146(2):205-12. PubMed ID: 23102506
[TBL] [Abstract][Full Text] [Related]
9. Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study.
Rahman S; Shanta AA; Daria S; Nahar Z; Shahriar M; Qusar MS; Islam SMA; Bhuiyan MA; Islam MR
PLoS One; 2022; 17(2):e0264404. PubMed ID: 35213631
[TBL] [Abstract][Full Text] [Related]
10. The Food-Specific Serum IgG Reactivity in Major Depressive Disorder Patients, Irritable Bowel Syndrome Patients and Healthy Controls.
Karakula-Juchnowicz H; Gałęcka M; Rog J; Bartnicka A; Łukaszewicz Z; Krukow P; Morylowska-Topolska J; Skonieczna-Zydecka K; Krajka T; Jonak K; Juchnowicz D
Nutrients; 2018 Apr; 10(5):. PubMed ID: 29710769
[TBL] [Abstract][Full Text] [Related]
11. Serum calcium levels and neuropsychological performance in depression and matched healthy controls: Reversal of correlation a marker of the aging cognitive clock?
Grützner TM; Listunova L; Fabian GA; Kramer BA; Flach D; Weisbrod M; Roesch-Ely D; Sharma A
Psychoneuroendocrinology; 2018 May; 91():198-205. PubMed ID: 29587243
[TBL] [Abstract][Full Text] [Related]
12. Serum FAM19A5 levels: A novel biomarker for neuroinflammation and neurodegeneration in major depressive disorder.
Han KM; Tae WS; Kim A; Kang Y; Kang W; Kang J; Kim YK; Kim B; Seong JY; Ham BJ
Brain Behav Immun; 2020 Jul; 87():852-859. PubMed ID: 32217080
[TBL] [Abstract][Full Text] [Related]
13. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum amino acids and non-enzymatic antioxidants in drug-naïve first-episode major depressive disorder.
Islam MR; Ali S; Karmoker JR; Kadir MF; Ahmed MU; Nahar Z; Islam SMA; Islam MS; Hasnat A; Islam MS
BMC Psychiatry; 2020 Jun; 20(1):333. PubMed ID: 32580709
[TBL] [Abstract][Full Text] [Related]
15. Relationship of Mean Platelet Volume To MDD: A Retrospective Study.
Cai L; Xu L; Wei L; Chen W
Shanghai Arch Psychiatry; 2017 Feb; 29(1):21-29. PubMed ID: 28769542
[TBL] [Abstract][Full Text] [Related]
16. Optic coherence tomography shows inflammation and degeneration in major depressive disorder patients correlated with disease severity.
Kalenderoglu A; Çelik M; Sevgi-Karadag A; Egilmez OB
J Affect Disord; 2016 Nov; 204():159-65. PubMed ID: 27344626
[TBL] [Abstract][Full Text] [Related]
17. The Association of Serum Complement C1q with Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Jia P; Wu Y; Gong Y; Jia Y; Wu X; Jian G
Altern Ther Health Med; 2024 Apr; ():. PubMed ID: 38607203
[TBL] [Abstract][Full Text] [Related]
18. Higher serum VGF protein levels discriminate bipolar depression from major depressive disorder.
Chen S; Jiang H; Hou Z; Yue Y; Zhang Y; Zhao F; Xu Z; Li Y; Mou X; Li L; Wang T; Zhao J; Han C; Sui Y; Wang M; Yang Z; Lu Y; Zhu Y; Li J; Shen X; Sun F; Chen Q; Yuan Y
J Neurosci Res; 2019 May; 97(5):597-606. PubMed ID: 30575991
[TBL] [Abstract][Full Text] [Related]
19. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
[TBL] [Abstract][Full Text] [Related]
20. Complement factor H and susceptibility to major depressive disorder in Han Chinese.
Zhang C; Zhang DF; Wu ZG; Peng DH; Chen J; Ni J; Tang W; Xu L; Yao YG; Fang YR
Br J Psychiatry; 2016 May; 208(5):446-52. PubMed ID: 26941266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
